Join to View Full Profile
6565 Fannin StHouston, TX 77030
Phone+1 713-441-1450
Fax+1 713-793-1232
Dr. Kamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Methodist Le Bonheur Healthcare/CentralResidency, Internal Medicine, 1999 - 2001
University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 1997 - 1999
J.L.N. Medicine Coll, Ravishankar Shukla UniversityClass of 1991
Certifications & Licensure
TX State Medical License 2006 - 2026
OK State Medical License 2001 - 2006
AR State Medical License 2001 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Rituximab for GVHD Start of enrollment: 2007 Jun 01
- Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) Start of enrollment: 2007 Jun 01
- Phase I Study of CD19 Chimeric Receptor Expressing T Lymphocytes in B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia [CRETI-NH] Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- CD19 directed CAR T therapy for intravascular large B-cell lymphoma.Jinalben Patel, Ajay Gopal, Hannah Cherniawsky, Ron Ram, Rammurti Kamble
Haematologica. 2025-11-06 - Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience.Khush Patel, Zoe H Tu, Carrie Yuen, Siddhartha Ganguly, Allison N Yun
JHLT Open. 2025-08-01 - 1 citationsEfficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.Ibrahim N Muhsen, Kristen E Shaver, Tao Wang, Mengfen Wu, Premal Lulla
Transplantation and Cellular Therapy. 2024-12-01
Abstracts/Posters
- T Cell Immunity Toward Viral- and Tumor-Antigens Is Preserved in MDS PatientsRammurti Kamble, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients with Multiple MyelomaRammurti Kamble, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
